Version: September 6, 2001

This document describes the role of the medical director, the knowledge needed to fill that role, and the available resources to provide that knowledge. It is intended to be used as a guide for educational efforts and a benchmark with which to evaluate them. The focus is on common needs with emphasis on principles, tools and sources of knowledge rather than specific facts. As our roles evolve, so must this document and our educational efforts.

Mission Statement of the Continuing Medical Education Committee of the American Academy of Insurance Medicine

To provide insurance medical directors with quality education that develops and
increases knowledge and skills used in life, health, disability and long term care insurance.

This will be accomplished by lectures, workshops, the Introductory Course for
medical directors, the Triennial Review, the Annual Scientific Program,
and other appropriate programs approved by the American Academy of Insurance Medicine.

The Academy will also endeavor to assist other organizations with an interest in insurance medicine and who provide quality education to their memberships by providing joint sponsorship for approved programs.

Role of the Insurance Medical Director

The role of the insurance medical director is to obtain and utilize current medical knowledge for the purpose of evaluating expected and actual mortality, morbidity, disability and the value of medical interventions.

Basic Knowledge Required to Perform Effectively as a Medical Director

I. General insurance and insurance medical principles, practices, law and ethics in each of the following areas:
A. Life insurance underwriting and claims
B. Disability income underwriting and claims
C. Structured settlements
D. Long term care insurance
E. Health insurance underwriting and claims

II. Mortality and morbidity analysis, including an understanding and working knowledge of:
A. Population life tables
B. Mortality curves and life expectancy
C. Select and ultimate mortality
D. Common patterns for diseases and other health-related conditions, and rating approaches
E. Sensitivity, specificity and predictive values
F. Mortality methodology
G. Value and limitations of examinations, laboratory testing and other diagnostic methods
H. Protective value studies

III. Medical Information Bureau (MIB): function, legal aspects and medical director responsibilities

IV. The mortality/morbidity impact of health-related conditions and behaviors, and the effectiveness of current therapy, including each of the following subject areas:
- epidemiology (including who is at risk and relative importance and age specific considerations)
- mortality patterns (e.g. fixed vs. temporary extra, table, early vs. late, the impact of age)
- risk factors
- genetic factors
- screening techniques (availability and effectiveness)
- diagnostics (the physical examination, laboratory and other diagnostic studies – availability, accuracy and limitations)
- impact of therapy
- prognostic factors

The subjects listed under the following headings highlight commonly encountered conditions. This is not an all-inclusive list.

A. Genetics 1. Basic principles of genetics and molecular biology
2. Genetic testing: basic methodology; clinical applications; ethical, legal and social issues
B. Infectious diseases 1. HIV
2. Other
C. Cardiovascular 1. EKG, stress test, imaging and invasive test interpretation
2. Hypertension
3. Atherosclerotic disease, including risk factors and impact of medical, interventional and surgical therapy
a) Coronary artery disease
b) Peripheral arterial disease
c) Cerebrovascular disease
4. Valvular heart disease
5. Cardiomyopathies
6. Congenital heart disease
7. Venous thromboembolism
D. Endocrine/
Metabolism
1. Diabetes mellitus
2. Thyroid disorders
3. Pituitary disorders
4. Lipid disorders
5. Obesity
E. Gastrointestinal 1. GI bleeding
2. Inflammatory bowel disease
3. Liver enzyme abnormalities
4. Chronic hepatitis
5. Hemochromatosis
6. Barrett’s esophagus
F. Genitourinary 1. Proteinuria and albuminuria
2. Chronic renal insufficiency
3. Adult polycystic kidney disease
4. Glomerulonephritis
5. Neurogenic bladder
6. Renal transplantation
G. Hematology/
Oncology
1. Anemias
2. Leukemias
3. Myeloproliferative disorders
4. Breast cancer
5. Prostate cancer (including PSA interpretation)
6. Colon polyps and cancer
7. Lymphoma
8. Skin cancers, including melanoma
9. Bladder cancer
10. Endometrial cancer
11. Cervical neoplasia
12. Lung cancer
13. Monoclonal gammopathy
14. Second malignancies
15. Bone marrow and stem cell transplantation
H. Musculoskeletal/
Rheumatology
1. Connective tissue disorders
a) Rheumatoid arthritis
b) Systemic lupus erythematosus
2. Osteoporosis
3. Cervical and lumbar disc disease
4. Osteoarthritis
5. Fibromyalgia
6. Chronic fatigue syndrome
7. Back pain
I. Neurology 1. Developmental disorders
2. Cerebral palsy
3. Mental retardation
4. Seizure disorders
5. Parkinson’s disease
6. Multiple sclerosis
7. Spinal cord injuries
8. Dementias
J. Psychiatry 1. Affective disorders
2. Anxiety disorders
3. Schizophrenia and other thought disorders
4. Attention deficit/hyperactivity disorder
5. Suicide risk
K. Respiratory 1. Asthma
2. COPD
3. Sleep apnea
4. Sarcoidosis and other inflammatory/infiltrative lung disorders
L. Substance Use 1. Alcohol
2. Tobacco
3. Illicit drug use
4. Prescription drug misuse/abuse
M. “Non-medical” Factors 1. Sports
2. Aviation
3. Foreign travel
4. Military service
5. Occupation

Recommended Resources for Mortality and Insurance Medicine Information

I. Texts, journals and published studies
A. Medical Risks: Trends in Mortality by Age and Time Elapsed
B. Medical Risks: 1991 Compend of Mortality and Morbidity
C. Medical Selection of Life Risks (Brackenridge)
D. Journal of Insurance Medicine
E. Underwriting publications, including On the Risk

II. Internet-based resources
A. PubMed search tool for Medline
B. Society of Actuaries with various mortality tables
C. Latest in SEER survival statistics for various malignancies
D. Mortality and other data on malignant diseases
E. Latest in survival and disease free survival for BMT in various malignancies
F. Latest organ transplant survival and other data on transplants covering the entire US

III. Self study programs
A. Life Office Management Association (LOMA) series, especially 280, 290, and 310
B. Academy of Life Underwriting (ALU) series
C. Chartered Life Underwriter (CLU) series, especially 323/324

IV. Training programs and meetings
A. Triennial Course in Insurance Medicine
B. Introduction to Insurance Medicine
C. Basic Mortality Methodology
D. Advanced Mortality Methodology
E. The AAIM annual meeting
F. Other industry meetings

V. Insurance Medicine professional organizations and certifying body
A. American Academy of Insurance Medicine (AAIM)
B. Board of Insurance Medicine (examination and certifying body of AAIM)
C. American Council of Life Insurers (ACLI) Medical Section
D. Canadian Life Insurance Medical Officers Association (CLIMOA)
E. International Committee of Life, Disability and Health Assurance Medicine (ICLAM)
F. Regional and local organizations, including the Midwest Medical Directors Association, the Midatlantic Medical Directors Association and the Twin Cities Medical Directors Association

VI. Related professional organizations
A. Association of Home Office Underwriters (AHOU)
B. Canadian Institute of Underwriting (CIU)
C. Society of Actuaries (SOA)
D. American Academy of Disability-Evaluating Physicians (AADEP)
E. Health Insurance Association of America (HIAA)
F. American College of Medical Quality
G. American College of Physician Executives


 
©2007 The American Academy of Insurance Medicine All rights reserved | Site Map | Disclaimer | Privacy Policy | Resources
Website Designed in Vancouver by Graphically Speaking